Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BSH 2017 | How can fatigue be recognized and managed?

Claire Harrison • 27 Mar 2017
BSH 2017

Claire Harrison, MD, DM, FRCP, FRCPath, from the Guy’s and St. Thomas’ NHS Foundation Trust, London, UK, discusses fatigue management at the 2017 British Society for Haematology (BSH) Annual Scientific Meeting in Brighton, UK. She highlights that not all fatigue relates to disease, but may be related to side effects of therapy. Dr Harrison also speaks about different ways in which fatigue can be managed.

More from Claire Harrison

Novel agents and approaches being explored in second-line myelofibrosis
14:29
Novel agents and approaches being explored in second-line myelofibrosis
Claire Harrison et al. • 2 Oct 2026
Reflecting on progress in MPN research and care: a lifetime perspective
2:01
Reflecting on progress in MPN research and care: a lifetime perspective
Claire Harrison • 13 Jun 2026
Updated data with INCA033989, a mutant CALR-specific mAb, in patients with MPNs
3:58
Updated data with INCA033989, a mutant CALR-specific mAb, in patients with MPNs
Claire Harrison • 13 Jun 2026
The Phase III SENTRY trial: selinexor plus ruxolitinib in JAK inhibitor-naïve myelofibrosis
2:41
The Phase III SENTRY trial: selinexor plus ruxolitinib in JAK inhibitor-naïve myelofibrosis
Claire Harrison • 13 Jun 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals